Business
Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions
RUTHERFORD, N.J., May 26, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that company leadership will present on its fully implantable continuous blood glucose monitoring (CBGM) technology at the American Diabetes Association’s (ADA) 2026 Scientific Sessions, taking place in New Orleans, June 5 – 8, 2026.
About this update from Glucotrack, Inc.
[{"type":"image","alt":"Glucotrack, Inc.","displaySize":"","headline":null,"caption":"Glucotrack, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":64,"url":"https://media.zenfs.com/en/globenewswire.com/55d126c2f85c074ae4df3a352637b3fb"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/wXqQ4CyH8jC1otLKDaakMA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTkw/https://media.zenfs.com/en/globenewswire.com/55d126c2f85c074ae4df3a352637b3fb","width":300,"height":64},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/wXqQ4CyH8jC1otLKDaakMA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTkw/https://media.zenfs.com/en/globenewswire.com/55d126c2f85c074ae4df3a352637b3fb","width":300,"height":64}},"lazy":false},{"type":"text","content":"RUTHERFORD, N.J., May 26, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that company leadership will present on its fully implantable continuous blood glucose monitoring (CBGM) technology at the American Diabetes Association’s (ADA) 2026 Scientific Sessions, taking place in New Orleans, June 5 – 8, 2026.","length":500,"tagName":"p"},{"type":"text","content":"As part of the ADA’s Innovation Hub, Mark Tapsak, PhD, Glucotrack’s Chief Scientific Officer, will present on the potential of next-generation CGM technology that addresses unmet patient needs through direct blood measurements (providing more accurate readings), multi-year implant longevity, and a fully implantable design that eliminates on-body wearables.","length":358,"tagName":"p"},{"type":"text","content":"Presentation Details:","length":21,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Update on Continuous Blood Glucose Monitoring Technology","length":56,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Date and Time: Saturday, June 6, 2:10 – 2:30 p.m. CDT","length":58,"tagName":"p"}]},{"val":[{"type":"text","content":"Location: Innovation Hub, ADA 2026","length":34,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":92,"olType":false}]}],"tagName":"ul","bulletedList":true,"length":148,"olType":false},{"type":"text","content":"“We look forward to presenting at ADA’s Scientific Sessions,” said Paul V....